GEVO:NSC-Gevo Inc. (USD)

EQUITY | Specialty Chemicals | NASDAQ Capital Market

Last Closing

USD 1.16

Change

0.00 (0.00)%

Market Cap

USD 0.04B

Volume

1.67M

Analyst Target

USD 3.52
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Gevo Inc is a renewable chemicals and biofuels company. It is engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-10 )

Largest Industry Peers for Specialty Chemicals

Symbol Name Price(Change) Market Cap
LIN Linde plc Ordinary Shares

+1.76 (+0.39%)

USD 208.95B
BCPC Balchem Corporation

+1.00 (+0.61%)

USD 5.28B
WDFC WD-40 Company

+5.39 (+2.33%)

USD 3.04B
HWKN Hawkins Inc

-1.92 (-1.60%)

USD 2.63B
IOSP Innospec Inc

+0.19 (+0.21%)

USD 2.27B
CLMT Calumet Specialty Products Par..

+0.80 (+6.49%)

USD 1.07B
HDSN Hudson Technologies Inc

+0.26 (+3.49%)

USD 0.24B
LWLG Lightwave Logic Inc

+0.05 (+4.95%)

USD 0.11B
FEAM 5E Advanced Materials Inc

-0.09 (-2.04%)

USD 0.08B
NTIC Northern Technologies

+0.08 (+1.10%)

USD 0.07B

ETFs Containing GEVO

G1CE:F Invesco Markets II Plc - .. 1.29 % 0.00 %

+0.83 (+0%)

N/A
G1CE:XETRA Invesco Global Clean Ener.. 0.00 % 0.00 %

+0.57 (+0%)

N/A
DKRB 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Specialty Chemicals) Market Performance vs. Exchange (NASDAQ Capital Market)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -44.50% 42% F 14% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -44.50% 42% F 14% F
Trailing 12 Months  
Capital Gain 62.08% 95% A 91% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 62.08% 95% A 91% A-
Trailing 5 Years  
Capital Gain 9.43% 33% F 50% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.43% 25% F 44% F
Average Annual (5 Year Horizon)  
Capital Gain 1,800.83% 100% F 98% N/A
Dividend Return 1,800.83% 100% F 98% N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 10,489.79% 5% F 2% F
Risk Adjusted Return 17.17% 53% F 53% F
Market Capitalization 0.04B 67% D+ 56% F

Key Financial Ratios

  Ratio vs. Industry/Classification (Specialty Chemicals) Ratio vs. Market (NASDAQ Capital Market)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 0.30 92% 95%
Price/Book Ratio 0.58 76% 85%
Price / Cash Flow Ratio -4.97 78% 80%
Price/Free Cash Flow Ratio 1.68 71% 54%
Management Effectiveness  
Return on Equity -15.02% 47% 46%
Return on Invested Capital -15.37% 26% 36%
Return on Assets -8.69% 35% 36%
Debt to Equity Ratio 13.71% 73% 64%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector